KEY TAKEAWAYS:

• Florida’s First District Court of Appeal has clarified that “pharmacist” does not include dispensing practitioners – only licensed pharmacists and pharmacies fall within the “absolute choice” statute – invalidating earlier regulatory efforts by the Department of Financial Services

• Carriers can regain control over medication authorization and costs by relying on established pharmacy networks and cost‑control programs without violating “absolute choice”

• The decision does not prohibit physicians from dispensing altogether – it simply restores the requirement that such dispensing be authorized and medically necessary

Florida’s First District Court of Appeal (DCA) has issued a decision that reshapes how prescription medications may be dispensed in workers’ compensation claims, which will result in cost savings on these medications for insurance companies responsible for covering the cost of the prescriptions. In a significant clarification, the DCA held that doctors who are registered as dispensing practitioners are not “pharmacists” under Florida’s long‑standing “absolute choice” statute – meaning injured workers may no longer rely on this provision to obtain medications directly from their physicians.

The ruling reverses recent regulatory efforts by the Department of Financial Services (DFS) to expand the definition of pharmacist to include dispensing physicians. For carriers and employers, this means renewed ability to manage where and how prescriptions are filled, helping rein in rising medication costs and restoring predictability to the authorization process.

Implications for Employers and Carriers

This decision significantly reshapes how prescription medications may be dispensed in Florida workers’ compensation claims. By holding that dispensing practitioners are not pharmacists under 440.13(3)(j), the First DCA has made clear that the statutory “absolute choice” provision does not entitle injured workers to obtain medications directly from their treating physicians unless the carrier separately authorizes it.

In short, the DCA reaffirmed that only pharmacies and licensed pharmacists fall within the legislature’s definition – meaning carriers retain the ability to manage and direct prescription dispensing locations more effectively. This decision also eliminates the regulatory ambiguity created when the DFS previously attempted, through rulemaking, to treat dispensing physicians as pharmacists.

The ruling restores cost‑containment mechanisms that had been undermined by in‑office dispensing:

• Carriers may once again deny authorization for in‑office physician dispensing when the request is not medically necessary or not otherwise authorized.
• Physicians cannot bypass normal authorization processes by providing medication at the point of service and claiming protection under the “absolute choice” statute.
• Reimbursement obligations remain unchanged for medications dispensed by authorized dispensing practitioners under 440.13(12)(c), but only when the carrier has authorized that dispensing.

Next Steps for Claim Handlers

• Review internal claims-handling procedures to ensure adjusters understand when in‑office dispensing can be denied.
• Reinforce authorization protocols for medications to prevent improper billing or retroactive dispensing.
• Monitor physician practices that may continue in‑office dispensing under the incorrect assumption that the 2020 DFS interpretation remains valid.
• Consider communicating this change to your provider networks to avoid unnecessary disputes.

If you have questions about how this decision affects your claims management strategies, vendor relationships, or authorization workflows, the Goldberg Segalla Workers’ Compensation team is ready to assist with guidance and implementation.